Company Press Releases

Antibiotic-sparing wound gel shows real promise in fighting biofilm infection
17th November 2017

Read more »

SurgihoneyRO officially recognised by NHS
11th October 2017

Read more »

Reactive Oxygen research wins innovation award
5th April 2017

Read more »

UCLH pilot study on impact of SurgihoneyRO in preventing surgical site infection
5th April 2017

Read more »

Development of Reactive Oxygen as a novel adjuvant antibiofilm agent in Staph. aureus-related chronic rhinosinusitis
30th March 2017

Mr Rami Salib, Consultant Ear, Nose and Throat Surgeon and Associate Professor of Rhinology, outlines ground-breaking research by the Southampton Upper Airway Research Group at the University of Southampton. Mr Salib leads the group.

Read more »

Doctor treats remote tribe in Papua, Indonesian New Guinea
30th January 2017

Read more »

Politics First – Reactive Oxygen highlighted as potential breakthrough in battle against superbugs
10th January 2017

In article for Politics First, a UK political magazine, MP Andrea Jenkyns, a member of the Health Select Committee, highlights how 300,000 people a year affected by healthcare-associated infections, including MRSA. Hospital infections cost the NHS £1billion a year. Shockingly, up to 40 per cent of those infections are preventable. “Refreshingly, we are now beginning to see…

Read More »

Reactive Oxygen hailed in The Times as British breakthrough in war against antimicrobial resistance
19th December 2016

Leading science writer, Matt Ridley, in his column for The Times highlights Surgihoney and Reactive Oxygen technology as a “British breakthough that could be of enormous significance in the war against antimicrobial resistance.”

Read more »

University researchers developing new Reactive Oxygen spray
5th October 2016

Read more »

Reactive Oxygen highlighted in House of Lords as new weapon to fight superbugs
16th September 2016

Read more »

Surgihoney RO helping patients in developing world
26th July 2016

In Burkina Faso, a country in West Africa, a baby boy with severe burns was among the first to be treated with Surgihoney Reactive Oxygen sterile wound gel at a health centre run by charity International Needs.

Read more »

Reactive Oxygen under the spotlight in House of Commons
6th July 2016

Reactive Oxygen comes under the spotlight in the House of Commons as “incredibly exciting new development” in fight against antimicrobial resistance.

Read more »

SurgihoneyRO Featured at Wound Care Conference
26th January 2016

SURGIHONEY NEW WEAPON TO FIGHT SUPERBUGS Surgihoney will feature at an international conference on wound healing as a new weapon to fight antimicrobial resistance. Professor Jonathan Cooke, Imperial College London and Manchester University, is presenting at the EuroSciCon event on January 27, 2016.  The symposium, in London’s O2 building, is for scientists and clinicians to discuss…

Read More »

Surgihoney™ in prestigious International Wound Journal
6th January 2016

Matoke Holdings Ltd (formerly known as Healing Honey International) announces that SurgihoneyTM has been highlighted as a promising new treatment in the International Wound Journal, December 2015 issue. The article, entitled ‘Reactive Oxygen Species (ROS) and wound healing: the functional role of ROS and emerging ROS-modulating technologies for the augmentation of the healing process,’ highlights the…

Read More »

University of Southampton investigates potential benefits of Surgihoney in treating chronic rhinosinusitis
5th January 2016

With millions predicted to die because of global drug resistance, the search is on for new solutions. University of Southampton researchers are working to investigate the potential benefits of Surgihoney in treating chronic rhinosinusitis. The bioengineered medical honey is a potent antimicrobial agent with antibiofilm activity.  It can destroy Gram-positive and Gram-negative bacteria, including multi-drug resistant…

Read More »

1 2